Sponsor of the Day:
Jerkmate
https://venturelabs.ca/canadian-government-supports-sfu-venturelabs-alumni-aspect-biosystems-with-79-million-in-funding/
Canadian Government supports SFU VentureLabs Alumni, Aspect Biosystems with $79 Million in Funding...
Apr 9, 2026 - On April 2nd, the Government of Canada announced an investment of $79 Million for SFU VentureLabs Alumni, Aspect Biosystems. This initiative was conducted...
canadian governmentsfu venturelabsaspect biosystemssupportsalumni
https://www.aspectbiosystems.com/
Aspect Biosystems | Bioprinting Tissue Therapeutics
Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
aspect biosystemsbioprintingtissuetherapeutics
https://www.biotalent.ca/organizations/aspect-biosystems-2/
Aspect Biosystems - BioTalent Canada
Aspect Biosystems is a Canadian biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most...
aspect biosystemsbiotalent canada
https://financialpost.com/pmn/business-wire-news-releases-pmn/aspect-biosystems-announces-280-million-partnership-with-government-of-canada-to-advance-development-of-bioengineered-cellular-medicines
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance...
aspect biosystems280 millionannouncespartnershipgovernment
https://aspectbiosystems.com/news-resources
Access News & Resources | Aspect Biosystems
Stay up to date with our latest news, events, and resources.
access newsaspect biosystemsresources
https://www.aspectbiosystems.com/careers
Join our Team | Aspect Biosystems
Join our diverse team of innovators – scientists, engineers, and business professionals – on our mission to transform medicine with bioprinted tissue...
aspect biosystemsjointeam
https://aspectbiosystems.com/
Aspect Biosystems | Bioprinting Tissue Therapeutics
Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
aspect biosystemsbioprintingtissuetherapeutics